Combination chemotherapy with gemcitabine and irinotecan in patients with previously treated carcinoma of an unknown primary siteThe following institutions are Minnie Pearl Cancer Research Network Participating Sites: Tennessee Oncology, PLLC (Nashville, TN); Wellstar Cancer Research (Marietta, GA); Consultants in Blood Disorders & Cancer (Louisville, KY); Graves‐Gilbert Clinic (Bowling Green, KY); Grand Rapids CCOP (Grand Rapids, MI); Upstate Carolina CCOP (Spartanburg, SC); Northeast Georgia Medical Center (Gainesville, GA); King's Daughters' Medical Center (Ashland, KY); Pheobe Cancer Center (Albany, GA); The Reading Hospital and Medical Center (Reading, PA); and Montana Cancer Specialists (Missoula, MT).: A Minnie Pearl Cancer Research Network Phase II trial

MLA

Hainsworth, John D., et al. “Combination Chemotherapy with Gemcitabine and Irinotecan in Patients with Previously Treated Carcinoma of an Unknown Primary SiteThe Following Institutions Are Minnie Pearl Cancer Research Network Participating Sites: Tennessee Oncology, PLLC (Nashville, TN); Wellstar Cancer Research (Marietta, GA); Consultants in Blood Disorders & Cancer (Louisville, KY); Graves‐Gilbert Clinic (Bowling Green, KY); Grand Rapids CCOP (Grand Rapids, MI); Upstate Carolina CCOP (Spartanburg, SC); Northeast Georgia Medical Center (Gainesville, GA); King’s Daughters’ Medical Center (Ashland, KY); Pheobe Cancer Center (Albany, GA); The Reading Hospital and Medical Center (Reading, PA); and Montana Cancer Specialists (Missoula, MT).: A Minnie Pearl Cancer Research Network Phase II Trial.” Cancer, vol. 104, no. 9, Nov. 2005, pp. 1992–97. EBSCOhost, https://doi.org/10.1002/cncr.21416.

APA

Hainsworth, J. D., Spigel, D. R., Raefsky, E. L., Kuzur, M. E., Yost, K., Kommor, M., Litchy, S., & Greco, F. A. (2005). Combination chemotherapy with gemcitabine and irinotecan in patients with previously treated carcinoma of an unknown primary siteThe following institutions are Minnie Pearl Cancer Research Network Participating Sites: Tennessee Oncology, PLLC (Nashville, TN); Wellstar Cancer Research (Marietta, GA); Consultants in Blood Disorders & Cancer (Louisville, KY); Graves‐Gilbert Clinic (Bowling Green, KY); Grand Rapids CCOP (Grand Rapids, MI); Upstate Carolina CCOP (Spartanburg, SC); Northeast Georgia Medical Center (Gainesville, GA); King’s Daughters’ Medical Center (Ashland, KY); Pheobe Cancer Center (Albany, GA); The Reading Hospital and Medical Center (Reading, PA); and Montana Cancer Specialists (Missoula, MT).: A Minnie Pearl Cancer Research Network Phase II trial. Cancer, 104(9), 1992–1997. https://doi.org/10.1002/cncr.21416

Chicago

Hainsworth, John D., David R. Spigel, Eric L. Raefsky, Michel E. Kuzur, Kathleen Yost, Michael Kommor, Sharlene Litchy, and F. Anthony Greco. 2005. “Combination Chemotherapy with Gemcitabine and Irinotecan in Patients with Previously Treated Carcinoma of an Unknown Primary SiteThe Following Institutions Are Minnie Pearl Cancer Research Network Participating Sites: Tennessee Oncology, PLLC (Nashville, TN); Wellstar Cancer Research (Marietta, GA); Consultants in Blood Disorders & Cancer (Louisville, KY); Graves‐Gilbert Clinic (Bowling Green, KY); Grand Rapids CCOP (Grand Rapids, MI); Upstate Carolina CCOP (Spartanburg, SC); Northeast Georgia Medical Center (Gainesville, GA); King’s Daughters’ Medical Center (Ashland, KY); Pheobe Cancer Center (Albany, GA); The Reading Hospital and Medical Center (Reading, PA); and Montana Cancer Specialists (Missoula, MT).: A Minnie Pearl Cancer Research Network Phase II Trial.” Cancer 104 (9): 1992–97. doi:10.1002/cncr.21416.